Table 3.
Univariate Cox regression analysis for MACE at follow-up.
| Unadjusted | |||
|---|---|---|---|
| Variable | HR | 95% CI | p-Value * |
| Age | 1.03 | 1.02–1.07 | <0.001 |
| Gender (male reference) | 0.63 | 0.44–1.01 | 0.056 |
| Hypertension | 2.29 | 1.47–3.35 | <0.001 |
| Hyperlipidemia | 1.46 | 1.12–2.35 | 0.021 |
| Hemoglobin | 0.89 | 0.81–0.97 | 0.119 |
| Creatinine, mg/dL | 0.96 | 0.41–3.75 | 0.934 |
| CRP; mg/dL | 1.03 | 1.01–1.12 | <0.001 |
| Family history of CAD | 1.10 | 0.67–1.87 | 0.599 |
| Smoking | 1.15 | 0.81–1.57 | 0.311 |
| LDL-C, mmol/L | 0.89 | 0.71–1.09 | 0.337 |
| HDL-C, mmol/L | 0.66 | 0.53–0.72 | 0.289 |
| OAD, n (%) | 0.74 | 0.61–0.91 | 0.323 |
| Antihyperlipidemic, n (%) | 0.91 | 0.72–0.99 | 0.453 |
| BMI | 1.01 | 0.90–1.27 | 0.396 |
| CAD-RADS (3, 4a, 4b, 5) | 4.74 | 3.35–7.45 | <0.001 |
| TyG index | 4.29 | 3.11–6.79 | <0.001 |
| AIP | 3.42 | 3.00–5.68 | <0.001 |
* p < 0.05 was considered statistically significant. Abbreviations: AIP, atherogenic index of plasma; BMI, Body mass index, CAD, coronary artery disease; CAD-RADS, Coronary Artery Disease–Reporting and Data System; CRP, C-reactive protein; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; OAD, oral antidiabetic drug; TyG, triglyceride–glucose index.